CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Restricted Stock	Options And Restricted Stock	Total Callaway Golf Company Shareholders' Equity	Total Callaway Golf Company Shareholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Total Callaway Golf Company Shareholders' Equity Restricted Stock	Total Callaway Golf Company Shareholders' Equity Options And Restricted Stock	Common Stock	Common Stock Options And Restricted Stock	Additional Paid-in Capital	Additional Paid-in Capital Restricted Stock	Additional Paid-in Capital Options And Restricted Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive (Loss) Income	Treasury Stock	Non-controlling Interest
Balance at beginning of period (in shares) at Dec. 31, 2018									95,649								1,138
Balance at beginning of period at Dec. 31, 2018	$ 734,308				$ 724,574				$ 956		$ 341,241			$ 413,799		$ (13,700)	$ (17,722)	$ 9,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Acquisition of treasury stock (in shares)																	(1,690)
Acquisition of treasury stock	(28,073)				(28,073)												$ (28,073)
Exercise of stock options (in shares)																	56
Exercise of stock options	368				368						(560)						$ 928
Compensatory awards released from restriction (in shares)																	1,318
Compensatory awards released from restriction	0				0						(20,656)						$ 20,656
Share-based compensation	12,896				12,896						12,896
Stock dividends (in shares)																	(3)
Stock dividends	0				0						1			(49)			$ 48
Cash dividends	(3,776)				(3,776)									(3,776)
Equity adjustment from foreign currency translation	(4,751)				(4,412)											(4,412)		(339)
Change in fair value of derivative instruments, net of tax	(4,310)				(4,310)											(4,310)
Acquisition of non-controlling interests	18,538				9,322						9,322							9,216
Net income (loss)	79,229				79,408									79,408				(179)
Balance at end of period (in shares) at Dec. 31, 2019									95,649								1,451
Balance at end of period at Dec. 31, 2019	$ 767,353	$ (289)			767,353	$ (289)			$ 956		323,600			489,382	$ (289)	(22,422)	$ (24,163)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2019-05 [Member]
Acquisition of treasury stock (in shares)																	(1,181)
Acquisition of treasury stock	$ (22,213)				(22,213)												$ (22,213)
Exercise of stock options (in shares)																	37
Exercise of stock options	248				248						(390)						$ 638
Compensatory awards released from restriction (in shares)																	1,144
Compensatory awards released from restriction	0				0						(19,762)						$ 19,762
Share-based compensation	10,927				10,927						10,927
Stock dividends (in shares)																	(5)
Stock dividends	0				0						3			(40)			$ 37
Cash dividends	(1,891)				(1,891)									(1,891)
Equity adjustment from foreign currency translation	25,690				25,690											25,690
Change in fair value of derivative instruments, net of tax	(9,814)				(9,814)											(9,814)
Equity component of convertible notes, net of issuance costs and tax	57,080				57,080						57,080
Premiums paid for capped call confirmations, net of tax	(24,513)				(24,513)						(24,513)
Net income (loss)	(126,934)				(126,934)									(126,934)
Balance at end of period (in shares) at Dec. 31, 2020									95,649								1,446
Balance at end of period at Dec. 31, 2020	675,644				675,644				$ 956		346,945			360,228		(6,546)	$ (25,939)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)									89,776	188
Common stock issued	2,650,201			$ 0	2,650,201			$ 0	$ 898	$ 2	2,649,303		$ (2)
Acquisition of treasury stock (in shares)																	(1,380)
Acquisition of treasury stock	$ (38,137)				(38,137)						353						$ (38,490)
Exercise of stock options (in shares)	1,436								520								916
Exercise of stock options	$ 22,270				22,270				$ 6		1,777						$ 20,487
Compensatory awards released from restriction (in shares)									39								949
Compensatory awards released from restriction	0				0						(18,532)						$ 18,532
Share-based compensation	38,685		$ 33,051		38,685		$ 33,051				38,685	$ 33,051
Stock dividends (in shares)																	(1)
Stock dividends	0				0						24			(48)			$ 24
Cash dividends	(3)				(3)									(3)
Equity adjustment from foreign currency translation	(29,215)				(29,215)											(29,215)
Change in fair value of derivative instruments, net of tax	8,418				8,418											8,418
Net income (loss)	321,988				321,988									321,988
Balance at end of period (in shares) at Dec. 31, 2021									186,172								960
Balance at end of period at Dec. 31, 2021	$ 3,682,902				$ 3,682,902				$ 1,862		$ 3,051,604			$ 682,165		$ (27,343)	$ (25,386)	$ 0